Wide variation and patterns of physicians' responses to drug-drug interaction alerts

被引:11
|
作者
Cho, Insook [1 ,2 ,3 ]
Lee, Yura [4 ]
Lee, Jae-Ho [4 ,5 ]
Bates, David W. [2 ,3 ,6 ]
机构
[1] Inha Univ, Dept Nursing, Incheon 22212, South Korea
[2] Brigham & Womens Hosp, Div Gen Internal Med, Ctr Patient Safety Res & Practice, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Asan Med Ctr, Dept Biomed Informat, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[6] Partners Healthcare Syst, Wellesley, MA 02481 USA
基金
美国医疗保健研究与质量局;
关键词
computerized physician order entry; drug-drug interaction; alert override; behavior pattern; variation analysis; BEHAVIOR; OVERRIDE;
D O I
10.1093/intqhc/mzy102
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives Providing physicians with alerts about potentially harmful drug-drug interactions (DDIs) is only moderately effective due to high alert override rates. To understand high override behavior on DDI alerts, we investigated how physicians respond to DDIs and their behavior patterns and variations. Design Retrospective system log data analysis and records review (sampling 2% of total overrides). Setting A large tertiary academic hospital. Participants About 560 physicians and their override responses to DDI alerts generated from 1 September to 31 December 2014. Interventions Not applicable. Main Outcome Measure(s) DDI alert frequency and override rate. Results We found significant variation in both the number of alerts and override rates at the levels of physicians, departments and drug-class pairs. Physician-level variations were wider for residents than for faculty staff (number of alerts: t = 254.17, P = 0.011; override rates: t = -4.77, P < 0.0001). Using the number of alerts and their override rate, we classified physicians into four groups: inexperienced incautious users, inexperienced cautious users, experienced cautious users and experienced incautious users. Medical department influenced both alert numbers and override rates. Nearly 90% of the overrides involved only five drug-class combinations, which had a wide range of appropriateness in the chart review. Conclusion The variations at drug-class levels suggest issues with system design and the DDI rules. Department-level variation may be best addressed at the department level, and the rest of the variation appears related to individual physician responses, suggesting the need for interventions at an individual level.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 50 条
  • [1] Physicians' responses to computerized drug-drug interaction alerts for outpatients
    Yeh, Min-Li
    Chang, Ying-Jui
    Wang, Po-Yen
    Li, Yu-Chuan
    Hsu, Chien-Yeh
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2013, 111 (01) : 17 - 25
  • [2] Participatory design for drug-drug interaction alerts
    Luna, Daniel
    Otero, Carlos
    Almerares, Alfredo
    Stanziola, Enrique
    Risk, Marcelo
    Gonzalez Bernaldo de Quiros, Fernan
    [J]. DIGITAL HEALTHCARE EMPOWERING EUROPEANS, 2015, 210 : 45 - 49
  • [3] Consider the Content of Drug-Drug Interaction Alerts
    Sweidan, Michelle
    Reeve, James F.
    Dartnell, Jonathan G. A.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (14) : 1338 - 1338
  • [4] Provider and pharmacist responses to warfarin drug-drug interaction alerts: a study of healthcare downstream of CPOE alerts
    Miller, Allison M.
    Boro, Maureen S.
    Korman, Nancy E.
    Ben Davoren, J.
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2011, 18 : I45 - I50
  • [5] Physicians' responses to computerized drug interaction alerts with password overrides
    Nasuhara, Yasuyuki
    Sakushima, Ken
    Endoh, Akira
    Umeki, Reona
    Oki, Hiromitsu
    Yamada, Takehiro
    Iseki, Ken
    Ishikawa, Makoto
    [J]. BMC MEDICAL INFORMATICS AND DECISION MAKING, 2015, 15
  • [6] Physicians’ responses to computerized drug interaction alerts with password overrides
    Yasuyuki Nasuhara
    Ken Sakushima
    Akira Endoh
    Reona Umeki
    Hiromitsu Oki
    Takehiro Yamada
    Ken Iseki
    Makoto Ishikawa
    [J]. BMC Medical Informatics and Decision Making, 15
  • [7] Clinician Perceptions of Timing and Presentation of Drug-Drug Interaction Alerts
    Humphrey, Kate E.
    Mirica, Maria
    Phansalkar, Shobha
    Ozonoff, Al
    Harper, Marvin B.
    [J]. APPLIED CLINICAL INFORMATICS, 2020, 11 (03): : 487 - 496
  • [8] Evaluation of Contraindicated Drug-Drug Interaction Alerts in a Hospital Setting
    Hatton, Randy C.
    Rosenberg, Amy F.
    Morris, Candice T.
    McKelvey, Russell P.
    Lewis, James R.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (03) : 297 - 308
  • [9] Improving the specificity of drug-drug interaction alerts: Can it be done?
    Reese, Thomas
    Wright, Adam
    Liu, Siru
    Boyce, Richard
    Romero, Andrew
    Del Fiol, Guilherme
    Kawamoto, Kensaku
    Malone, Daniel
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (13) : 1086 - 1095
  • [10] Optimizing Drug-Drug Interaction Alerts Using a Multidimensional Approach
    Daniels, Calvin C.
    Burlison, Jonathan D.
    Baker, Donald K.
    Robertson, Jennifer
    Sablauer, Andras
    Flynn, Patricia M.
    Campbell, Patrick K.
    Hoffman, James M.
    [J]. PEDIATRICS, 2019, 143 (03)